retatrutide expanded access program eli lilly Lilly's cuts weight by 17% in diabetes trial Eli Lilly's Retatrutide Delivers Bariatric-Style

As a GLP-1 receptor agonist , this peptide is a critical tool in advancing clinical research related to diabetes therapy , obesity management , and weight loss

Finasteride and Dutasteride, are the two clinically approved inhibitors available in the market, that helps in reducing the prostate volume by blocking the 5a-reductase enzyme

Some clinicians recommend a microdosing approach to tirzepatide for patients who are particularly sensitive to side effects

Thus, this review synthesizes global evidence on the cost-effectiveness of GLP-1 RAs, ESG, and MBS and discusses implications for Korean health policy

There are different types of carnitine supplements available, like acetyl-L-carnitine (ALCAR) and L-carnitine L-tartrate (LCLT)